S100A9 is upregulated in sepsis patient’s blood sample and is associated with various complications of sepsis, including sepsis-induced acute liver injury (Zhang et al., 2023), sepsis-induced myocardial dysfunction (Jakobsson et al., 2023) and lung damage (Ding et al., 2021). The gene discussed is S100A9; the disease is Sepsis.